Drug Prices
3 Ways Drug Pricing Reforms in Congress Will Help People
Drug Prices
3 Ways Drug Pricing Reforms in Congress Will Help People
Physician on a Mission: Prescribing Timely FDA Reforms to Ensure Patient Safety
Drug Prices
Physician on a Mission: Prescribing Timely FDA Reforms to Ensure Patient Safety
Q&A
High Brand-Name Net Prices — and List Prices — Support Reforms to Medicare Part D
Drug Prices
High Brand-Name Net Prices — and List Prices — Support Reforms to Medicare Part D
Medicare Negotiation Hearing: 3 Key Takeaways
Drug Prices
Medicare Negotiation Hearing: 3 Key Takeaways
Aduhelm Only Latest Drug to Make Case for Reform
Drug Prices
Aduhelm Only Latest Drug to Make Case for Reform
A New Generation in the Fight for Fair Drug Prices
Drug Prices
A New Generation in the Fight for Fair Drug Prices
Q&A
A New Way to Begin the End of HIV in the U.S.
Drug Prices
A New Way to Begin the End of HIV in the U.S.
Q&A
5 Things to Watch in Health Care in 2022
Drug Prices
5 Things to Watch in Health Care in 2022
Look Ahead
Fallout From Controversial Alzheimer's Drug Continues
Drug Prices
Fallout From Controversial Alzheimer’s Drug Continues
Congress: Pharma's Price Gouging is Purposeful
Drug Prices
Congress: Pharma’s Price Gouging is Purposeful
Maximizing Opportunity, Minimizing Injustice for Our Nation’s Veterans
Drug Prices
Maximizing Opportunity, Minimizing Injustice for Our Nation’s Veterans
Drug Pricing Reform Failure is Unacceptable
Drug Prices
Drug Pricing Reform Failure is Unacceptable
Op-Ed
Part 3: After a Groundswell of Success in 2021, Stage is Set for Broader Rx Reform in 2022
Drug Prices
Part 3: After a Groundswell of Success in 2021, Stage is Set for Broader Rx Reform in 2022
Drug Affordability
Part 2: In Quest to Lower Rx Prices, States Deploy New Tools
Drug Prices
Part 2: In Quest to Lower Rx Prices, States Deploy New Tools
Drug Affordability
Part 1: As Congress Debates Lowering Drug Prices, States Waste No Time
Drug Prices
Part 1: As Congress Debates Lowering Drug Prices, States Waste No Time
Drug Affordability
FDA's Pfizer Vaccine Approval is Proof that Public-Private Partnerships Work
Drug Prices
FDA’s Pfizer Vaccine Approval is Proof that Public-Private Partnerships Work
Biden Takes Aim at Drug Prices with Executive Order. Does it Go Far Enough?
Drug Prices
Biden Takes Aim at Drug Prices with Executive Order. Does it Go Far Enough?
MACPAC Recommends Policies To Reduce Spending on High Cost Specialty Drugs in the Medicaid Program
Drug Prices
MACPAC Recommends Policies To Reduce Spending on High Cost Specialty Drugs in the Medicaid Program
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.